SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19181778
Source:
http://linkedlifedata.com/resource/pubmed/id/19181778
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026986
,
umls-concept:C0030705
,
umls-concept:C0038250
,
umls-concept:C0181904
,
umls-concept:C0596972
,
umls-concept:C0728873
,
umls-concept:C0871261
,
umls-concept:C1144149
,
umls-concept:C1332710
,
umls-concept:C1442161
,
umls-concept:C1521461
,
umls-concept:C1521743
,
umls-concept:C1704632
,
umls-concept:C1704646
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
3
pubmed:dateCreated
2009-3-2
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19181778-11753621
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19181778-12611065
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19181778-15703420
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19181778-17021321
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19181778-18591621
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0417435
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
,
http://linkedlifedata.com/resource/pubmed/chemical/lenalidomide
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1592-8721
pubmed:author
pubmed-author:EhningerGerhardG
,
pubmed-author:MohrBrigitteB
,
pubmed-author:OelschlaegelUtaU
,
pubmed-author:PlatzbeckerUweU
,
pubmed-author:StewartMichelle MeredythMM
,
pubmed-author:ThiedeChristianC
pubmed:issnType
Electronic
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
430-1
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:19181778-Aged
,
pubmed-meshheading:19181778-Antigens, CD34
,
pubmed-meshheading:19181778-Antineoplastic Agents
,
pubmed-meshheading:19181778-Chromosome Deletion
,
pubmed-meshheading:19181778-Chromosomes, Human, Pair 5
,
pubmed-meshheading:19181778-Cytogenetic Analysis
,
pubmed-meshheading:19181778-Female
,
pubmed-meshheading:19181778-Hematopoietic Stem Cells
,
pubmed-meshheading:19181778-Humans
,
pubmed-meshheading:19181778-In Situ Hybridization, Fluorescence
,
pubmed-meshheading:19181778-Karyotyping
,
pubmed-meshheading:19181778-Male
,
pubmed-meshheading:19181778-Middle Aged
,
pubmed-meshheading:19181778-Myelodysplastic Syndromes
,
pubmed-meshheading:19181778-Thalidomide
,
pubmed-meshheading:19181778-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells.
pubmed:publicationType
Letter
,
Case Reports